Display options
Cite
Hatzibaloglou A, Velissaris I, Kaitzis D, et al. ProCol vascular bioprosthesis for vascular access: midterm results. J Vasc Access. 2004;5(1):16-8doi: 10.1177/112972980400500104.
Hatzibaloglou, A., Velissaris, I., Kaitzis, D., Grekas, D., Avdelidou, A., & Kiskinis, D. (2004). ProCol vascular bioprosthesis for vascular access: midterm results. The journal of vascular access, 5(1), 16-8. https://doi.org/10.1177/112972980400500104
Hatzibaloglou, A, et al. "ProCol vascular bioprosthesis for vascular access: midterm results." The journal of vascular access vol. 5,1 (2004): 16-8. doi: https://doi.org/10.1177/112972980400500104
Hatzibaloglou A, Velissaris I, Kaitzis D, Grekas D, Avdelidou A, Kiskinis D. ProCol vascular bioprosthesis for vascular access: midterm results. J Vasc Access. 2004 Jan-Mar;5(1):16-8. doi: 10.1177/112972980400500104. PMID: 16596534.
Copy Download .nbib Format: NLM
Share it on

J Vasc Access. 2004 Jan-Mar;5(1):16-8. doi: 10.1177/112972980400500104.

ProCol vascular bioprosthesis for vascular access: midterm results.

The journal of vascular access

A Hatzibaloglou, I Velissaris, D Kaitzis, D Grekas, A Avdelidou, D Kiskinis

Affiliations

  1. 1st Surgical and 1st Medical Department, AHEPA University Hospital, Thessaloniki, Greece.

PMID: 16596534 DOI: 10.1177/112972980400500104

Abstract

BACKGROUND/AIMS: This study aimed to evaluate the safety and efficacy of the ProCol vascular bioprostheses as vascular access (VA) material, especially in patients with a history of prior failed access.

METHODS: During a 20-month period, 25 arteriovenous (AV) bovine vein grafts were placed in 24 hemodialysis (HD) patients for VA. All patients presented with failed autologous access sites.

RESULTS: Graft placement was successful in all patients with no procedure-related complications. Follow-up from 6-26 months gave primary 6-month, 12-month and 24-month patency rates of, respectively, 90%, 80% and 70%. Graft characteristics in cannulation and hemostasis were very satisfying.

CONCLUSION: Our midterm results demonstrated that the ProCol vascular bioprosthesis was a promising material for VA with good patency and low complication rates.

Publication Types